163 related articles for article (PubMed ID: 7735878)
1. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Brain; 1995 Apr; 118 ( Pt 2)():359-68. PubMed ID: 7735878
[TBL] [Abstract][Full Text] [Related]
2. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.
Bromberg MB; Feldman EL; Albers JW
Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
Gorson KC; Allam G; Ropper AH
Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
[TBL] [Abstract][Full Text] [Related]
5. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients.
Sghirlanzoni A; Solari A; Ciano C; Mariotti C; Fallica E; Pareyson D
Neurol Sci; 2000 Feb; 21(1):31-7. PubMed ID: 10938200
[TBL] [Abstract][Full Text] [Related]
7. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
8. Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia.
Cocito D; Durelli L; Isoardo G
Acta Neurol Scand; 2003 Oct; 108(4):274-80. PubMed ID: 12956862
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy.
Notermans NC; Franssen H; Eurelings M; Van der Graaf Y; Wokke JH
Muscle Nerve; 2000 Jan; 23(1):73-9. PubMed ID: 10590408
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults.
Simmons Z; Wald JJ; Albers JW
Muscle Nerve; 1997 Dec; 20(12):1569-75. PubMed ID: 9390670
[TBL] [Abstract][Full Text] [Related]
11. Multiple Myeloma Associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Importance of Continued Surveillance.
Fasanya AA; Loncharich MF; Gandhi V; Rana S; Balaan M
Cureus; 2016 Nov; 8(11):e899. PubMed ID: 28070468
[TBL] [Abstract][Full Text] [Related]
12. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
[TBL] [Abstract][Full Text] [Related]
13. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.
Notermans NC; Wokke JH; Lokhorst HM; Franssen H; van der Graaf Y; Jennekens FG
Brain; 1994 Dec; 117 ( Pt 6)():1385-93. PubMed ID: 7820574
[TBL] [Abstract][Full Text] [Related]
14. Focal neuropathy preceding chronic inflammatory demyelinating polyradiculoneuropathy by several years.
Verma A; Tandan R; Adesina AM; Pendlebury WW; Fries TJ; Bradley WG
Acta Neurol Scand; 1990 Jun; 81(6):516-21. PubMed ID: 2171295
[TBL] [Abstract][Full Text] [Related]
15. Severe CIDP-MGUS responsive to Rituximab.
Posa A; Emmer A; Kornhuber M
Heliyon; 2020 Jun; 6(6):e04230. PubMed ID: 32596526
[TBL] [Abstract][Full Text] [Related]
16. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance.
Di Troia A; Carpo M; Meucci N; Pellegrino C; Allaria S; Gemignani F; Marbini A; Mantegazza R; Sciolla R; Manfredini E; Scarlato G; Nobile-Orazio E
J Neurol Sci; 1999 Mar; 164(1):64-71. PubMed ID: 10385050
[TBL] [Abstract][Full Text] [Related]
18. [Paraproteinemic neuropathies: foundations for a specific therapy related to patients' quality of life].
Casadevall Codina T; Pérez Lázaro C; Santos S; Fabre Pi O; Garcés Redondo M; Larrodé Pellicer P
Rev Neurol; 2004 Apr 1-15; 38(7):631-6. PubMed ID: 15098183
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
Wilson J; Chawla J; Fisher M
J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
[TBL] [Abstract][Full Text] [Related]
20. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
